Keyword: Sarasin David Kaegi

News

Sanofi Hopes To Win Genzyme For $76/Share

14.01.2011 - French drugmaker Sanofi-Aventis hopes to reach a takeover deal that would value U.S. target Genzyme at around $76 per share, or some $20 billion, the French daily newspaper Le...

News

Genzyme Acknowledges Sanofi Talks, Quick Deal Hopes Cool

11.01.2011 - Genzyme acknowledged on Monday that it was discussing a takeover deal with French drugmaker Sanofi-Aventis, but hopes for a quick agreement cooled as both sides noted differences...